You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 15, 2026

Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models
Published on: October 3, 2019
Qiurong Ding1, Youn-Kyoung Lee, Esperance A K Schaefer
1Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA.
Transcription activator-like effector nucleases (TALENs) enable rapid genome editing in human cells. This technology facilitates the study of gene function and disease mechanisms by creating precise mutations.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: